XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 63 filers reported holding XENON PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $104,553,128 | -9.4% | 2,681,537 | 0.0% | 0.02% | -10.5% |
Q1 2024 | $115,440,168 | -6.5% | 2,681,537 | 0.0% | 0.02% | -13.6% |
Q4 2023 | $123,511,594 | +58.9% | 2,681,537 | +17.9% | 0.02% | +46.7% |
Q3 2023 | $77,713,112 | -11.3% | 2,274,974 | 0.0% | 0.02% | -11.8% |
Q2 2023 | $87,586,499 | +7.6% | 2,274,974 | 0.0% | 0.02% | 0.0% |
Q1 2023 | $81,421,319 | -9.2% | 2,274,974 | 0.0% | 0.02% | -10.5% |
Q4 2022 | $89,702,225 | +9.2% | 2,274,974 | 0.0% | 0.02% | +5.6% |
Q3 2022 | $82,127,000 | +18.7% | 2,274,974 | 0.0% | 0.02% | +20.0% |
Q2 2022 | $69,205,000 | -0.5% | 2,274,974 | 0.0% | 0.02% | +25.0% |
Q1 2022 | $69,546,000 | -2.1% | 2,274,974 | 0.0% | 0.01% | +9.1% |
Q4 2021 | $71,070,000 | +382.7% | 2,274,974 | +136.1% | 0.01% | +266.7% |
Q3 2021 | $14,722,000 | -17.9% | 963,500 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $17,940,000 | +4.0% | 963,500 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $17,247,000 | +16.4% | 963,500 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $14,819,000 | +38.9% | 963,500 | 0.0% | 0.00% | +50.0% |
Q3 2020 | $10,666,000 | -11.7% | 963,500 | 0.0% | 0.00% | -33.3% |
Q2 2020 | $12,082,000 | +10.6% | 963,500 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $10,926,000 | -13.5% | 963,500 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $12,631,000 | +45.5% | 963,500 | 0.0% | 0.00% | +50.0% |
Q3 2019 | $8,681,000 | -8.6% | 963,500 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $9,500,000 | -3.0% | 963,500 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $9,789,000 | +61.0% | 963,500 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $6,080,000 | -52.2% | 963,500 | 0.0% | 0.00% | -33.3% |
Q3 2018 | $12,718,000 | -3.3% | 963,500 | -32.6% | 0.00% | 0.0% |
Q2 2018 | $13,147,000 | +87.8% | 1,429,000 | 0.0% | 0.00% | +50.0% |
Q1 2018 | $7,002,000 | +73.4% | 1,429,000 | 0.0% | 0.00% | +100.0% |
Q4 2017 | $4,037,000 | -4.2% | 1,429,000 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $4,216,000 | -6.3% | 1,429,000 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $4,501,000 | -21.3% | 1,429,000 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $5,716,000 | -39.4% | 1,429,000 | +16.7% | 0.00% | -50.0% |
Q4 2016 | $9,433,000 | +13.1% | 1,225,000 | +18.9% | 0.00% | 0.0% |
Q3 2016 | $8,343,000 | +36.8% | 1,030,000 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $6,098,000 | -15.3% | 1,030,000 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $7,200,000 | -13.1% | 1,030,000 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $8,281,000 | -2.7% | 1,030,000 | 0.0% | 0.00% | -33.3% |
Q3 2015 | $8,508,000 | +11.9% | 1,030,000 | +56.2% | 0.00% | +50.0% |
Q2 2015 | $7,604,000 | -31.6% | 659,497 | 0.0% | 0.00% | -33.3% |
Q1 2015 | $11,122,000 | -5.2% | 659,497 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $11,732,000 | – | 659,497 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 3,516,851 | $44,101,000 | 2.72% |
Parkman Healthcare Partners LLC | 590,267 | $7,402,000 | 2.08% |
ACUTA CAPITAL PARTNERS, LLC | 517,500 | $6,489,000 | 1.88% |
Soleus Capital Management, L.P. | 250,897 | $3,146,000 | 1.79% |
DAFNA Capital Management LLC | 346,535 | $4,346,000 | 1.25% |
KNOTT DAVID M | 169,000 | $2,119,000 | 1.16% |
Ghost Tree Capital, LLC | 325,000 | $4,076,000 | 1.08% |
Avoro Capital Advisors LLC | 2,800,000 | $35,112,000 | 0.69% |
NEA Management Company, LLC | 992,107 | $12,441,000 | 0.50% |
Orbimed Advisors | 2,497,917 | $31,324,000 | 0.44% |